Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

The effectiveness of statins for women with PCOS is unclear.

The medication cyproterone acetate/ethinylestradiol is usually prescribed correctly for acne after other treatments don't work.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Choosing the right estroprogestin is crucial for effectively managing PCOS symptoms.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Hormonal contraceptives are highly effective but require medical evaluation due to potential health risks.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.